2023-01-25 06:30:00

Sosei Heptares Webinar Presentation for FY2022 Financial Results

Logo GlobeNewswire
GlobeNewswire

TOKYO and CAMBRIDGE, United Kingdom, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Sosei Group Corporation (the Company; TSE: 4565), the world leader in G protein-coupled receptor (GPCR) focused structure-based drug design (SBDD) and development, will announce its earnings results and present operational highlights for the 12 months ended 31 December 2022 on Tuesday, 14 February 2023.

The Company will host a webinar presentation in-person and virtually for institutional investors, securities analysts and the press with Chris Cargill, President and CEO, and Hironoshin Nomura, CFO at 5 pm JST (8 am GMT) in Tokyo.

The webinar is open to all existing and potential investors as well and will consist of a presentation followed by a Q&A session. Please click here to pre-register, which will provide a link to access the webinar. Japanese/English simultaneous interpretation will be provided.

Presentation slides will be made available by 3:30 pm JST (6:30 am GMT) on 14 February 2023 through the investor section of the Companys Home Page here. Archive streaming will be available here on the companys website after the event.

About Sosei Heptares
We are an international biopharmaceutical group focused on the discovery and early development of new medicines originating from our proprietary GPCR-targeted StaR technology and structure-based drug design platform capabilities. We are advancing a broad and deep pipeline of novel medicines across multiple therapeutic areas, including neurology, immunology, gastroenterology, and inflammatory diseases.

We have established partnerships with some of the worlds leading pharmaceutical companies and multiple emerging technology companies, including AbbVie, AstraZeneca, Genentech (Roche), GSK, Kallyope, Lilly, Neurocrine Biosciences, Novartis, Pfizer, Takeda and Verily. Sosei Heptares is headquartered in Tokyo, Japan with corporate and R&D facilities in Cambridge, UK.

Sosei Heptares is the corporate brand and trademark of Sosei Group Corporation, which is listed on the Tokyo Stock Exchange (ticker: 4565). Sosei, Heptares, the logo and StaR are trademarks of Sosei Group companies.

For more information, please visit https://soseiheptares.com/
LinkedIn: @soseiheptaresco | Twitter: @soseiheptaresco | YouTube: @soseiheptaresco

Enquiries:

Sosei Heptares Media and Investor Relations

Hironoshin Nomura, Chief Financial Officer
Shinichiro Nishishita, VP Investor Relations, Head of Regulatory Disclosures
Candelle Chong, SVP Investor Relations and Corporate Strategy
Japan: +81 (0)3 5210 3399 | United Kingdom: +44 (0)1223 949390 | IR@SoseiHeptares.com

MEDiSTRAVA Consulting (for International Media)
Mark Swallow, Frazer Hall, Eleanor Perkin
+44 (0)203 928 6900 | SoseiHeptares@medistrava.com

Forward-looking statements
This press release contains forward-looking statements, including statements about the discovery, development, and commercialization of products. Various risks may cause Sosei Group Corporations actual results to differ materially from those expressed or implied by the forward-looking statements, including: adverse results in clinical development programs; failure to obtain patent protection for inventions; commercial limitations imposed by patents owned or controlled by third parties; dependence upon strategic alliance partners to develop and commercialize products and services; difficulties or delays in obtaining regulatory approvals to market products and services resulting from development efforts; the requirement for substantial funding to conduct research and development and to expand commercialization activities; and product initiatives by competitors. As a result of these factors, prospective investors are cautioned not to rely on any forward-looking statements. We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


Continue read on globenewswire.com

Logo GlobeNewswire
SciencePress Release2023-01-24 13:00:00
CARMEL, Ind., Jan. 24, 2023 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc., a clinical stage biopharmaceutical company developing Precision Endocrine Peptide...

Logo PR Newswire
HealthPress Release2023-01-24 10:56:00
Two successful exits – Syndesi and BioPhero Four portfolio companies reported clinical data from first in class targets (Galecto, NMD Pharma, Heparegenix and...

Logo Benzinga
Business / FinanceBy Pr Newswire2023-01-24 17:14:00
Submission of EXXUA (gepirone HCl), a novel targeted single serotonin receptor agonist for treatment of Major Depressive Disorder receives PDUFA action date...

Logo GlobeNewswire
SciencePress Release2023-01-24 13:00:00
BOSTON, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Cerevance, a private, clinical-stage drug discovery and development company focused on central nervous system (CNS)...

Logo PR Newswire
HealthPress Release2023-01-24 17:14:00
Submission of EXXUA (gepirone HCl), a novel targeted single serotonin receptor agonist for treatment of Major Depressive Disorder receives PDUFA action date...

Logo PR Newswire
TechnologyPress Release2023-01-24 08:30:00
MUMBAI, India, Jan. 24, 2023 /PRNewswire/ -- Hexaware, a global technology and business process services company, has been recognized by the Institute of...

Logo Nasdaq
Business / FinanceBy The Motley Fool2023-01-24 14:15:30
SoFi (NASDAQ: SOFI) has caught many investors' eyes. However, in this episode, Jamie explains why he isn't ready to add SoFi stock to his portfolio just yet,...

Logo Channel NewsAsia
Business / FinanceBy Cna2023-01-24 08:42:57
Best News Website or Mobile Service WAN-IFRA Digital Media Awards Worldwide Best News Website or Mobile Service Digital Media Awards Worldwide STOCKHOLM :...

Logo GlobeNewswire
TechnologyPress Release2023-01-24 08:37:00
CAMBRIDGE, United Kingdom, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Bango (AIM: BGO), theglobal platform for data-driven commerce, provides an update on trading for...

Logo Nasdaq
TechnologyBy Zacks2023-01-24 13:50:00
For Immediate Release Chicago, IL January 24, 2023 Today, Zacks Investment Ideas feature highlights Jabil Inc. JBL, Salesforce CRM and NetEase NTES. These 3...

Logo Benzinga
Business / FinanceBy Business Wire2023-01-24 23:55:00
Today, prominent investor rights law firm Bernstein Litowitz Berger & Grossmann LLP ("BLB&G") filed a class action lawsuit in the U.S. District Court...

Logo PR Newswire
HealthPress Release2023-01-24 11:30:00
BOSTON, Jan. 24, 2023 /PRNewswire/ -- NanoMosaic, the pioneer and leader of nanoneedle technology (MosaicNeedle™) for proteomics and multiomics, announced...

Logo PR Newswire
HealthPress Release2023-01-24 15:00:00
DUBLIN, Jan. 24, 2023 /PRNewswire/ -- The "Immunofluorescence Assay Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering....

Logo PR Newswire
NEW YORK, Jan. 24, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Y-mAbs...

Logo PR Newswire
TechnologyPress Release2023-01-24 12:25:00
HOLON, Israel, Jan. 24, 2023 /PRNewswire/ -- Sapiens International Corporation (NASDAQ: SPNS) (TASE: SPNS), a leading global provider of software solutions...

Logo GlobeNewswire
TechnologyPress Release2023-01-24 14:05:00
ALISO VIEJO, Calif., Jan. 24, 2023 (GLOBE NEWSWIRE) -- WHO: Lori Mazan, President and Chief Coaching Officer of Sounding Board, the first unified Leader...

Logo Nasdaq
Business / FinanceBy Bnk Invest2023-01-24 18:47:00
In trading on Tuesday, the SPDR S&P Biotech ETF is outperforming other ETFs, up about 1.7% on the day. Components of that ETF showing particular strength...

Logo GlobeNewswire
SciencePress Release2023-01-24 12:00:00
BOCA RATON, Fla., Jan. 24, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (NASDAQ:FWBI) (First Wave BioPharma or the Company), a clinical-stage...

Logo PR Newswire
MONTREAL, Jan. 24, 2023 /CNW/ - Amphora Financial Group (Amphora), a provider of life insurance, trust and company management services, today announced a...

Logo GlobeNewswire
NEW YORK, NY, Jan. 24, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire --Institutional Analyst Inc (Institutional Analyst) issues Equity Research Report on Society...